author-photo

Linda Nicolardi

University of Padua

26

Papers

596

Citations

Citation Trend

Filter By

Papers (26) Sort By

Journal Conference Others

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (19)
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.

2021 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (0)
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort

2021 Journal of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (1)
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab

2021 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (6)
FP12.06 GRIm-Score Variations Predict Outcome in Metastatic NSCLC Patients Treated with First-Line Pembrolizumab

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (31)
Dextromethorphan phenotyping as a test for prediction of tamoxifen (TAM) activation in breast cancer patients receiving adjuvant hormone therapy.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The role of prognostic factors in metastatic renal cell carcinoma (mRCC) treated with targeted therapies (TT): Data from an Italian retrospective multicentric study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
CYP2D6 pharmacogenetic testing: Beliefs and psychological effects in breast cancer patients treated with adjuvant tamoxifen (T).

2013 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
2507 POSTER Temozolomide (TMZ) concomitant to radiotherapy (RT) plus 12 cycles of maintenance chemotherapy in newly diagnosed GBM: is more better?

2007 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (1)